A Medical Breakthrough for Postpartum Depression Within a Deeply Flawed System

(MedPage Today) -- The FDA approval of the postpartum depression (PPD) pill zuranolone (Zurzuvae), based on two successful phase III trials, represents a scientific triumph. This neuroactive steroid-based treatment joins a related treatment, IV...
Source: MedPage Today OB/GYN - Category: OBGYN Source Type: news